Early Alzheimer's Disease Clinical Research Study

TRAILRUNNER-ALZ 3 is a clinical study by Eli Lilly investigating whether an investigational medicine can slow or prevent early Alzheimer’s disease. The study focuses on individuals with early symptoms or at risk of developing the condition.

Be part of a study that could shape the future of Memory Care!

Get started now

Between 55 to 80 years old
Have no to mild issues with your memory
Willing to obtain a blood test as part of the study
Have a reliable study partner (spouse, partner, family member, friend, or someone else whose job is to help you)

Who is it for?

Access to potential new treatments before they are widely available
Free medical care and health monitoring during the study
Contribute to advancing medical research and helping future generations
If you qualify, you may be compensated for your time and travel

Benefits of participanting

How did you find us?
Are you between ages 55 and 80?
Do you have issues with memory?
Are you willing to obtain a blood test as part of the study that checks whether you have an abnormal protein associated with Alzheimer's disease?
Do you have a study partner - person who knows you well and would notice any changes in your memory, mood, and behavior? This could be your spouse, partner, friend, family member, or someone whose job it is to help you.

Don’t see what you’re looking for?

View other studies